These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4837701)

  • 21. Phentolamine blocks the somatostatin-mediated inhibition of insulin secretion.
    Smith PH; Woods SC; Porte D
    Endocrinology; 1976 Apr; 98(4):1073-6. PubMed ID: 776596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of alpha-adrenergic blockade on insulin secretion in man.
    Buse MG; Johnson AH; Kuperminc D; Buse J
    Metabolism; 1970 Mar; 19(3):219-25. PubMed ID: 4391985
    [No Abstract]   [Full Text] [Related]  

  • 23. Tranylcypromine: a potent insulin secretagogue and hypoglycemic agent.
    Bressler R; Vargas-Cord M; Lebovitz HE
    Diabetes; 1968 Oct; 17(10):617-24. PubMed ID: 4878653
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of prostaglandin E1 and of epinephrine on the dynamics of insulin release in vitro.
    Burr IM; Sharp R
    Endocrinology; 1974 Mar; 94(3):835-9. PubMed ID: 4591826
    [No Abstract]   [Full Text] [Related]  

  • 25. The adrenergic modulation of the serum insulin response to intravenous arginine in man.
    London DR; Bacchus RA; Bold AM; Meade L; Sacre M; Taberner M; Walker G
    Eur J Clin Invest; 1971 Nov; 2(1):52-8. PubMed ID: 5156957
    [No Abstract]   [Full Text] [Related]  

  • 26. Altered insulin and glucose metabolism produced by epinephrine during hemorrhagic shock in the adrenalectomized primate.
    Hiebert JM; Sixt N; Soeldner JS; Egdahl RH
    Surgery; 1973 Aug; 74(2):223-34. PubMed ID: 4197934
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inhibition of insulin secretion by alpha adrenergic stimulatory agents].
    Senft G; Sitt R; Losert W; Schultz G; Hoffmann M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(4):309-23. PubMed ID: 4300750
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of insulin release during hypovolemic shock.
    Cerchio GM; Persico PA; Jeffay H
    Metabolism; 1973 Dec; 22(12):1449-58. PubMed ID: 4202739
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of epinephrine and progesterone on the ocular hypertensive response to intravenous infusion of prostaglandin A2.
    Chiang TS
    Prostaglandins; 1973 Sep; 4(3):415-9. PubMed ID: 4205970
    [No Abstract]   [Full Text] [Related]  

  • 30. Glucagon stimulation of insulin release in man: inhibition during hypoglycemia.
    Goldfine ID; Cerasi E; Luft R
    J Clin Endocrinol Metab; 1972 Aug; 35(2):312-5. PubMed ID: 5072359
    [No Abstract]   [Full Text] [Related]  

  • 31. Beta adrenergic receptor dysfunction in hypoxic inhibition of insulin release.
    Baum D; Porte D
    Endocrinology; 1976 Feb; 98(2):359-66. PubMed ID: 1248452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of alpha- and beta adrenergic receptor blockaders on the secretory response of pancreatic beta cells in thyrotoxicosis].
    Zhurova TE; Lugovaia NA; Poltorak VV; Iurchenko MZ
    Ter Arkh; 1982; 54(10):36-9. PubMed ID: 6129711
    [No Abstract]   [Full Text] [Related]  

  • 33. Glucose intolerance and impaired secretion by prostaglandin A1 in fasting anesthetized dogs.
    Saccà L; Rengo F; Chiariello M; Condorelli M
    Endocrinology; 1973 Jan; 92(1):31-4. PubMed ID: 4681934
    [No Abstract]   [Full Text] [Related]  

  • 34. A release of prostaglandins may be responsible for acute tolerance to norepinephrine infusions.
    Gryglewski RJ; Ocetkiewicz A
    Prostaglandins; 1974 Oct; 8(1):31-42. PubMed ID: 4457957
    [No Abstract]   [Full Text] [Related]  

  • 35. Norepinephrine-induced insulin and substrate changes in normal man: incomplete reversal by phentolamine.
    Meguid MM; Moore Ede MC; Fitzpatrick G; Moore FD
    J Surg Res; 1975 Apr; 18(4):365-9. PubMed ID: 1142752
    [No Abstract]   [Full Text] [Related]  

  • 36. The stimulus-secretion coupling of glucose-induced insulin release. I. Interaction of epinephrine and alkaline earth cations.
    Malaisse WJ; Brisson G; Malaisse-Lagae F
    J Lab Clin Med; 1970 Dec; 76(6):895-902. PubMed ID: 4922110
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inhibition of the metabolic and circulatory (cardiovascular) effects of diazoxide through alpha--and beta-receptor blockade].
    Börner E; Biro G; Kettl H; Weinges KF
    Horm Metab Res; 1969 Nov; 1(6):296-300. PubMed ID: 4401003
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin release during alpha-adrenergic receptor blockade: primacy of the glycemic stimulus.
    Cryer PE; Herman CM; Sode J
    Endocrinology; 1971 Sep; 89(3):918-20. PubMed ID: 4398029
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of cyclic AMP and epinephrine on insulin and growth hormone secretion in sheep.
    Hertelendy F
    Horm Metab Res; 1971 Mar; 3(2):90-3. PubMed ID: 4330868
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs.
    Ferreira SH; Moncada S; Vane JR
    Br J Pharmacol; 1973 Sep; 49(1):86-97. PubMed ID: 4207046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.